Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Date of authorisation: 13/01/2012, Revision: 17, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HC, feline calicivirosis and feline viral rhinotracheitis vaccine (live), Status: Authorised

Human medicines European public assessment report (EPAR): Desloratadine ratiopharm, desloratadine, Date of authorisation: 13/01/2012, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Fycompa, perampanel, Date of authorisation: 23/07/2012, Revision: 36, Status: Authorised

Annex to interim measures regarding notification of pharmacovigilance alerts by marketing authorisation holders under Regulation (EU) 2019/6: contact points

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026

Human medicines European public assessment report (EPAR): Infanrix Hexa, diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed), Date of authorisation: 23/10/2000, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 40, Status: Authorised

PWCP 20th anniversary summary

EMEA-002601-PIP01-19